Making Cancer More Transparent

A decade into the age of genomics, science is generating a flood of data that will help in the quest to eradicate the disease.

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WIKIMEDIA COMMONSTen years ago this month, on April 14, 2003—50 years after Watson and Crick’s publication of DNA’s double helical structure—leaders of the Human Genome Project announced that the sequence was “essentially complete,” with more than 99 percent decoded. The news, which came less than 3 years after the highly heralded draft sequence had been revealed, served to increase the feeling of certainty that a much clearer understanding of the immensely complicated biology of cancer would be forthcoming in the near future.

For the last 10 years, innovative advances in sequencing techniques have generated terabytes of publicly available omics data, and costs have now come down to levels that make genome-wide sequencing of individual cancer patients feasible. Big science on steroids. The information derived from cancer genomics has begun to nudge open the door to truly personalized treatment, but it has also revealed that science will need a very fine-toothed comb to assess the effects of the many mutations within different tumor types and across different cancers.

In this issue of The Scientist, we take a look at some of the ways cancer researchers and clinicians are tackling a number of the disease’s still-refractory aspects. “Models of Transparency” details why the zebrafish, long a standard model for ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio